TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9706526

Group type: EXPERIMENTAL
Intervention: Lidocaine + prilocaine (active group)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Aqueous extract of Triticum vulgaris (placebo group)
Number of subjects: 119

Group type: COMPARATOR
Intervention: No anesthetic (control group)
Number of subjects: 119
Study: 8520640

Group type: EXPERIMENTAL
Intervention: 4.2 MJ diet daily with exercise
Number of subjects: 98

Group type: COMPARATOR
Intervention: 4.2 MJ diet daily without exercise
Number of subjects: 98
Study: 2146047

Group type: EXPERIMENTAL
Intervention: Danazol 600 mg daily for 6 months
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Goserelin 3.6 mg monthly depot injections for 6 months
Number of subjects: 30
Study: 386157

Group type: EXPERIMENTAL
Intervention: Methylprednisolone and cyclophosphamide pretreatment (5 g each)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (no pretreatment)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Methylprednisolone and cyclophosphamide pretreatment
Number of subjects: 34
Study: 31994303

Group type: EXPERIMENTAL
Intervention: 270 mg ferrous sulphate twice a day (total elemental iron dose: 160 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 270 mg ferrous sulphate once a day (total elemental iron dose: 80 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 270 mg ferrous sulphate every other day (total elemental iron dose: 80 mg/every other day)
Number of subjects: 0
Study: 31151337

Group type: EXPERIMENTAL
Intervention: Transforaminal Endoscopic Lumbar Discectomy (TELD)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Open Lumbar Microdiscectomy
Number of subjects: 298
Study: 28183552

Group type: EXPERIMENTAL
Intervention: Airtraq laryngoscope
Number of subjects: 46

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 46
Study: 26002204

Group type: EXPERIMENTAL
Intervention: Flexibility and balance exercises for 6 weeks
Number of subjects: 57

Group type: COMPARATOR
Intervention: Flexibility program (control group)
Number of subjects: 57
Study: 23314603

Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg orally daily for 3 days
Number of subjects: 276

Group type: COMPARATOR
Intervention: Metoclopramide 10 mg orally TID for 3 days
Number of subjects: 276
Study: 21884372

Group type: EXPERIMENTAL
Intervention: Odor of breast milk during gavage feeding
Number of subjects: 80
Study: 19019338

Group type: EXPERIMENTAL
Intervention: Motivated group (training protocol, no reading glasses for 3 months, cycloplegic eye drops for 10 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no special training protocol)
Number of subjects: 40
Study: 17595658

Group type: EXPERIMENTAL
Intervention: Vinorelbine/carboplatin (VC)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Gemcitabine/carboplatin (GC)
Number of subjects: 432
Study: 15179092

Group type: EXPERIMENTAL
Intervention: AH covered with ADMA
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: ABB covered with ADMA
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: AH covered with ePTFE
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: ABB covered with ePTFE
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: ADMA-covered sites
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: ePTFE-covered sites
Number of subjects: 15
Study: 11566255

Group type: EXPERIMENTAL
Intervention: Simvastatin and Niacin (S-N) therapy
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 9502662

Group type: EXPERIMENTAL
Intervention: Aggressive tocolysis with intravenous magnesium sulfate
Number of subjects: 145

Group type: COMPARATOR
Intervention: No tocolysis
Number of subjects: 145
Study: 30998533

Group type: EXPERIMENTAL
Intervention: PRBC+plasma
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Plasma
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: PRBC
Number of subjects: 407

Group type: COMPARATOR
Intervention: Crystalloid only
Number of subjects: 407

Group type: COMPARATOR
Intervention: Crystalloid volume
Number of subjects: 407
Study: 29882170

Group type: EXPERIMENTAL
Intervention: Laparoscopic repair (LG)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Hybrid repair (HG)
Number of subjects: 193
Study: 28893843

Group type: EXPERIMENTAL
Intervention: Coronary angiography (CAG) <12 hours
Number of subjects: 4071

Group type: COMPARATOR
Intervention: Coronary angiography (CAG) 12-24 hours
Number of subjects: 4071

Group type: COMPARATOR
Intervention: Coronary angiography (CAG) ≥24 hours
Number of subjects: 4071
Study: 25721702

Group type: EXPERIMENTAL
Intervention: Aged exercise group (n=6)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Young exercise group (n=6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Aged control group (n=5)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Young control group (n=6)
Number of subjects: 12
Study: 23229426

Group type: EXPERIMENTAL
Intervention: Autotransfusion system for washed shed blood (WSB) used for 6 hours (intraoperatively and postoperatively)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Regular drain without suction (Control Group B)
Number of subjects: 151
Study: 19231042

Group type: EXPERIMENTAL
Intervention: Formula with galacto- and fructo-oligosaccharides
Number of subjects: 342

Group type: COMPARATOR
Intervention: Control formula
Number of subjects: 342
Study: 17472992

Group type: EXPERIMENTAL
Intervention: Sitaxsentan 100 mg or 300 mg daily
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Sitaxsentan (in blinded extension study)
Number of subjects: 42
Study: 15306858

Group type: EXPERIMENTAL
Intervention: Open mesh repair
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional (McVay) repair
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sick leave of one to three weeks
Number of subjects: 40
Study: 12112913

Group type: EXPERIMENTAL
Intervention: 8 Fr IABC catheter
Number of subjects: 9332

Group type: COMPARATOR
Intervention: 9.5 Fr IABC catheter
Number of subjects: 9332
Study: 9615797

Group type: EXPERIMENTAL
Intervention: Granulocyte/macrophage colony stimulating factor (GM-CSF), administered as subcutaneous injections for 7 consecutive days to 14 patients.
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo, administered as subcutaneous injections for 7 consecutive days to 15 patients.
Number of subjects: 29
Study: 7708896

Group type: EXPERIMENTAL
Intervention: Melodic contexts using pure-tone sequences generated from diatonic or nondiatonic tonesets with manipulated pitch-distributional information.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melodic contexts using pure-tone sequences with fixed temporal order of tones.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diatonic sequences for musically trained listeners.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temporal location of tones in sequences (randomized across trials) for musically untrained listeners in Experiment 3.
Number of subjects: 0
Study: 2653015

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 98548

Group type: EXPERIMENTAL
Intervention: Early discharge (48 hours post-operation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long stay (6 to 7 days post-operation)
Number of subjects: 0
Study: 31533292

Group type: EXPERIMENTAL
Intervention: Qigong exercise session (video demonstration via website), delivered twice a day for 12 consecutive weeks
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control group (wait-list control)
Number of subjects: 282
Study: 28877225

Group type: EXPERIMENTAL
Intervention: Active water-based recovery
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Passive water-based recovery
Number of subjects: 17

Group type: COMPARATOR
Intervention: Active land-based recovery
Number of subjects: 17

Group type: COMPARATOR
Intervention: Passive land-based recovery
Number of subjects: 17
Study: 26083769

Group type: EXPERIMENTAL
Intervention: Mesotherapy with sodium diclofenac (25mg/1mL), 1mL for each session, three times per week for nine sessions.
Number of subjects: 117

Group type: COMPARATOR
Intervention: Oral administration of sodium diclofenac (50mg) once a day for 3 weeks.
Number of subjects: 117
Study: 23895817

Group type: EXPERIMENTAL
Intervention: aVR ST-deviation (ST-depression 5%, ST-elevation 10.2%)
Number of subjects: 5683

Group type: EXPERIMENTAL
Intervention: aVR ST-elevation
Number of subjects: 5683

Group type: EXPERIMENTAL
Intervention: aVR ST-depression
Number of subjects: 5683
Study: 21889083

Group type: EXPERIMENTAL
Intervention: Fixed orthodontic appliances
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 20
Study: 19660420

Group type: EXPERIMENTAL
Intervention: Nesiritide (0.01 microg x kg(‐1) x min(‐1) for 5 days)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 94
Study: 17311640

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bupivacaine 0.125%
Number of subjects: 40
Study: 15173400

Group type: EXPERIMENTAL
Intervention: Yeast-leavened oat bread with high molecular weight β-glucan (HMW) (797 kDa)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Yeast-leavened oat bread with low molecular weight β-glucan (LMW) (217 kDa)
Number of subjects: 22
Study: 11386413

Group type: EXPERIMENTAL
Intervention: High-dose (HD) chemotherapy
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Standard-dose (SD) chemotherapy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (not treated with chemotherapy)
Number of subjects: 47
Study: 9740230

Group type: EXPERIMENTAL
Intervention: 0.1% tacrolimus
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 0.3% tacrolimus
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Betamethasone-valerate
Number of subjects: 26

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 26
Study: 8002509

Group type: EXPERIMENTAL
Intervention: Glucose infusion (0.5 g/min) after placebo (Pl)
Number of subjects: 8
Study: 3201128

Group type: EXPERIMENTAL
Intervention: FF5005 (pectin-containing formulation)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Test meal (radiolabelled with technetium-99m)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: FF5005
Number of subjects: 6
Study: 31391479

Group type: EXPERIMENTAL
Intervention: Esketamine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 28199216

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 30
Study: 25932839

Group type: EXPERIMENTAL
Intervention: Manual vacuum aspiration
Number of subjects: 500

Group type: COMPARATOR
Intervention: Electric vacuum aspiration
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Manual vacuum aspiration (in pregnancies of sac size 3 mm or less)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Electric vacuum aspiration (in pregnancies of sac size 3 mm or less)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 500
Study: 24143900

Group type: COMPARATOR
Intervention: IV
Number of subjects: 12

Group type: COMPARATOR
Intervention: AL
Number of subjects: 12

Group type: COMPARATOR
Intervention: IV + OR
Number of subjects: 12

Group type: COMPARATOR
Intervention: NF
Number of subjects: 12

Group type: COMPARATOR
Intervention: NF, AL, OR, IV
Number of subjects: 12
Study: 21445574

Group type: EXPERIMENTAL
Intervention: Prophylactic lamivudine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (no prophylactic lamivudine)
Number of subjects: 42
Study: 19721848

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) in women with bulimia using serotonin reuptake inhibitors
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) in bulimic women not using medications
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) in normal-eater control women
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (normal-eater women)
Number of subjects: 64
Study: 17192328

Group type: EXPERIMENTAL
Intervention: orlistat 120 mg t.i.d.
Number of subjects: 383

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 383
Study: 15339330

Group type: EXPERIMENTAL
Intervention: Infliximab treatment (administered intravenously three times)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Infliximab treatment (once)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Infliximab treatment
Number of subjects: 42
Study: 12221344

Group type: EXPERIMENTAL
Intervention: Manipulative therapy
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study: 9704239

Group type: EXPERIMENTAL
Intervention: Diet treatment in Northern California (NoCal)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Insulin treatment in Northern California (NoCal)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Diet treatment in New England (NewEng)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Insulin treatment in New England (NewEng)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Premeal blood glucose testing in Southern California (SoCal)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Postprandial blood glucose testing in Southern California (SoCal)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Premeal blood glucose group in Southern California (SoCal)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Postprandial blood glucose group in Southern California (SoCal)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Postprandial monitoring in Southern California (SoCal)
Number of subjects: 3
Study: 8032580

Group type: EXPERIMENTAL
Intervention: Cadralazine 10 mg once daily
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg once daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Both cadralazine and chlorthalidone
Number of subjects: 14
Study: 2681087

Group type: EXPERIMENTAL
Intervention: Parenteral prophylaxis with cefazolin 1 g every 6 hours for 24 hours (2 g for knee-replacement)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Use of bone cement impregnated with antibiotics (e.g. Palacos-Gentamycin-cement)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Operation performed in a theater with 'ultra-clean-air' laminar air-flow and use of 'whole-body-exhaust' suits
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Antibiotic selection adjusted based on ongoing monitoring of antimicrobial resistance
Number of subjects: 105
Study: 8187

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 0
Study: 31676174

Group type: EXPERIMENTAL
Intervention: Gap balance technique
Number of subjects: 50

Group type: COMPARATOR
Intervention: Measured resection technique
Number of subjects: 50
Study: 30374683

Group type: EXPERIMENTAL
Intervention: 1500 mg CBD twice daily
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 750 mg CBD twice daily
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 1500 mg CBD single dose
Number of subjects: 42

Group type: COMPARATOR
Intervention: Single ascending doses (1500, 3000, 4500 or 6000 mg CBD)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Multiple dose (750 or 1500 mg CBD)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 27382815

Group type: EXPERIMENTAL
Intervention: Group M: 15 ml of bupivacaine 0.5% + 1 ml of 50 mg MgSO4
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group C: 15 ml of bupivacaine 0.5% + 1 ml of normal saline
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group M and Group C
Number of subjects: 40
Study: 25699352

Group type: EXPERIMENTAL
Intervention: Warm water infusion
Number of subjects: 122

Group type: COMPARATOR
Intervention: Standard air insufflation
Number of subjects: 122
Study: 23087776

Group type: EXPERIMENTAL
Intervention: Therapeutic massage (TM)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Relaxation control
Number of subjects: 35
Study: 21224783

Group type: EXPERIMENTAL
Intervention: Pilates exercises
Number of subjects: 52

Group type: COMPARATOR
Intervention: Home exercises
Number of subjects: 52
Study: 18052699

Group type: EXPERIMENTAL
Intervention: Anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Open flap debridement (OFD)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 12
Study: 16356805

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 4162

Group type: COMPARATOR
Intervention: Pravastatin 40 mg/day
Number of subjects: 4162
Study: 12121424

Group type: EXPERIMENTAL
Intervention: Brace with early range of motion (ROM) exercises from postoperative day 7
Number of subjects: 50

Group type: COMPARATOR
Intervention: Plaster immobilization with ROM exercises starting 4 weeks postoperatively
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 10402814

Group type: EXPERIMENTAL
Intervention: Propofol titration using BIS maintained at 40 during induction (n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bolus infusion of propofol 2 mg.kg‐1 (n = 15)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (titration and bolus)
Number of subjects: 30
Study: 7538179

Group type: EXPERIMENTAL
Intervention: Combination treatment using imipenem/cilastatin sodium (IPM/CS) with G-CSF
Number of subjects: 30

Group type: COMPARATOR
Intervention: Monotherapy on antibiotic
Number of subjects: 30

Group type: COMPARATOR
Intervention: IPM/CS in combination with other antibiotics
Number of subjects: 30
Study: 2248066

Group type: EXPERIMENTAL
Intervention: Moclobemide
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 7303774

Group type: EXPERIMENTAL
Intervention: Short-term lithium therapy (7 days) in combination with methimazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methimazole monotherapy
Number of subjects: 0
Study: 31615388

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of β‐AB and Ivabradine
Number of subjects: 0
Study: 28728604

Group type: EXPERIMENTAL
Intervention: CPT (clinical prediction tool) with matched treatment recommendation
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Usual care plus Target-D attention control
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: CPT (clinical prediction tool)
Number of subjects: 1320
Study: 26346932

Group type: EXPERIMENTAL
Intervention: Multimodal intervention including leadership commitment, surveillance of materials, reminders, storyboard, and feedback.
Number of subjects: 705

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Multimodal intervention (after adjustment for confounding factors).
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Multimodal intervention (univariate analysis).
Number of subjects: 705
Study: 23695914

Group type: EXPERIMENTAL
Intervention: Feedback-based (FB) instruction
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Paired-associate (PA) instruction
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Typical training condition
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Atypical training condition
Number of subjects: 26

Group type: COMPARATOR
Intervention: Nonaphasic controls
Number of subjects: 26
Study: 21775973

Group type: EXPERIMENTAL
Intervention: Frequent nocturnal hemodialysis (6 times per week)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Conventional hemodialysis (3 times per week)
Number of subjects: 87
Study: 19435763

Group type: EXPERIMENTAL
Intervention: Sample size calculation reporting
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Sample size calculation accuracy
Number of subjects: 215

Group type: COMPARATOR
Intervention: Assumptions for control group
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Overall reporting quality
Number of subjects: 215
Study: 17152087

Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral DCE-MRI with high frame-rate and 16x acceleration factor over conventional MR scans.
Number of subjects: 54
Study: 15061259

Group type: EXPERIMENTAL
Intervention: FDG PET imaging
Number of subjects: 10
Study: 11213884

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg once daily
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 2 mg twice daily
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 8 mg once daily
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg twice daily
Number of subjects: 959

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (all doses)
Number of subjects: 959
Study: 9609364

Group type: EXPERIMENTAL
Intervention: Surgical excision, debridement, and surgical closure (Group B)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conservative treatment (Group A)
Number of subjects: 42
Study: 7914307

Group type: EXPERIMENTAL
Intervention: 500 U/kg rhEPO subcutaneously twice a week for 3 weeks
Number of subjects: 95

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 95
Study: 2885878

Group type: EXPERIMENTAL
Intervention: Carbamazepine (average dose 1240 mg/day, blood levels 10.4 +/- 2.2 micrograms/ml)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Carbamazepine responders (12 patients)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Negative family history of affective illness (7 patients)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Positive family history of affective illness
Number of subjects: 19

Group type: COMPARATOR
Intervention: Nonresponders (7 patients)
Number of subjects: 19
Study: 30015503

Group type: EXPERIMENTAL
Intervention: Stories intervention (n=23, 5 women and 18 men)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Cognitive treatment control (n=24, 8 women and 16 men)
Number of subjects: 71
Study: 28372563

Group type: EXPERIMENTAL
Intervention: SMS programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0